Skip to content
    Palo Alto Networks logo

    Palo Alto Networks

    Santa Clara, California, United StatesFounded 2005

    Palo Alto Networks is the global cybersecurity leader, headquartered in Santa Clara, California. In July 2017, it formed the $20 million Palo Alto Networks Venture Fund to invest in seed-, early-, and growth-stage security companies with a cloud-based application approach.

    Average disclosed round size is $100.7M (across 7 rounds with reported amounts).

    Find people at Palo Alto Networks on Goldilocks AI

    Portfolio

    7

    Fund Size

    $20M

    Top Stage

    Series E

    Last 12 Mo

    0

    Team

    Carl Eschenbach

    Carl Eschenbach

    Partner, Sequoia Capital

    James J. Goetz

    James J. Goetz

    Partner, Sequoia Capital

    Aparna Bawa

    Aparna Bawa

    Executive Vice President, Chief Legal & People Officer, Intel Corporation

    Bruce R. Byrd

    Bruce R. Byrd

    Executive Vice President and General Counsel

    BJ Jenkins

    BJ Jenkins

    President

    Danielle Gonzalez

    Danielle Gonzalez

    Chief People Officer

    Dipak Golechha

    Dipak Golechha

    Chief Financial Officer

    Helle Thorning-Schmidt

    Helle Thorning-Schmidt

    Former Prime Minister of Denmark

    Helmut Reisinger

    Helmut Reisinger

    CEO for EMEA

    John M. Donovan

    John M. Donovan

    Former Chief Executive Officer, AT&T Communications, AT&T Inc.

    Karim Temsamani

    Karim Temsamani

    President, Next Generation Security

    Kelly Waldher

    Kelly Waldher

    Chief Marketing Officer

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    7 investments
    CompanyRoundAmountDate
    Cimento logoCimentoPre-Seed$3MJan 2026
    Skild AI logoSkild AIGrowth$500MJan 2025
    Endor Labs logoEndor LabsSeed$25MOct 2022
    BBuilder.aiSeries C$100MMar 2022
    Exactuals logoExactualsSeries A$10.6MJan 2017
    Revance Therapeutics logoRevance TherapeuticsSeries E$33M—
    Revance logoRevanceSeries E$33M—

    Top Co-Investors

    Last updated: 20 October 2026